Related Experiment Video
Updated: Sep 16, 2025
09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.8K
Modulating ovarian cancer progression through FDX1-driven autophagy
Chang Liu1, Siyu Wang2, Jiabao Zhao1
1Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, China.
NPJ Precision Oncology
|July 8, 2025
Summary
Ferredoxin 1 (FDX1) regulates autophagy and copper metabolism in ovarian cancer. Targeting FDX1 and enhancing autophagy shows promise for inhibiting tumor growth.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Ferredoxin 1 (FDX1) is implicated in cellular processes.
- Its specific role in ovarian cancer (OC) and its connection to autophagy require further elucidation.
Purpose of the Study:
- To investigate the function of FDX1 in ovarian cancer.
- To explore FDX1's role in regulating autophagy and copper metabolism.
- To assess FDX1 as a potential therapeutic target.
Main Methods:
- Cellular localization studies of FDX1.
- Analysis of FDX1's impact on AMPK and mTOR signaling pathways.
- Investigation of FDX1's role in mitochondrial integrity and DLAT/DLST sulfation.
- In vivo studies involving FDX1 overexpression and Compound C treatment.
Main Results:
- FDX1 is localized to the cytoplasm and mitochondria in OC cells.
- FDX1 modulates autophagy via AMPK and mTOR pathways, preserving mitochondrial function.
- FDX1 knockdown leads to mitochondrial dysfunction.
- Overexpression of FDX1 with Compound C inhibits tumor growth and Ki67 expression in vivo.
Conclusions:
- FDX1 is a key regulator of autophagy and mitochondrial integrity in ovarian cancer.
- FDX1 represents a promising therapeutic target for exploiting autophagy-based strategies against OC.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:18Autophagic Cell Death
3.6K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
01:27Autophagy
4.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
02:07Oogenesis
64.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.5K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
01:31The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K